Period of time： 2013年13期
Publisher： Future Science
Founded in： 2009
Total resources： 9
ISSN： 1756-8927
Subject： Q5 Biochemistry
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Future Medicinal Chemistry,volume 5,issue 13
Menu
Access to resources
Recommend
Glycine reuptake inhibition: a promising therapeutic strategy in the treatment of schizophrenia?
By Chue Pierre S,Baker Glen B in (2013)
Future Medicinal Chemistry,volume 5,issue 13 , Vol. 5, Iss. 13, 2013-09 , pp.Interview: Interview with P Jeffrey Conn
Future Medicinal Chemistry,volume 5,issue 13 , Vol. 5, Iss. 13, 2013-09 , pp.Therapeutic potential of isoform selective HDAC inhibitors for the treatment of schizophrenia
By Weïwer Michel,Lewis Michael C,Wagner Florence F,Holson Edward B in (2013)
Future Medicinal Chemistry,volume 5,issue 13 , Vol. 5, Iss. 13, 2013-09 , pp.Peptide POP inhibitors for the treatment of the cognitive symptoms of schizophrenia
By López Abraham,Mendieta Laura,Prades Roger,Royo Soledad,Tarragó Teresa,Giralt Ernest in (2013)
Future Medicinal Chemistry,volume 5,issue 13 , Vol. 5, Iss. 13, 2013-09 , pp.By Dawson Lee A,Porter Roderick A in (2013)
Future Medicinal Chemistry,volume 5,issue 13 , Vol. 5, Iss. 13, 2013-09 , pp.Cholinergic muscarinic receptors: new opportunities to treat psychiatric disorders
Future Medicinal Chemistry,volume 5,issue 13 , Vol. 5, Iss. 13, 2013-09 , pp.Candidate molecules for chemical chaperone therapy of GM1-gangliosidosis
By Higaki Katsumi,Ninomiya Haruaki,Suzuki Yoshiyuki,Nanba Eiji in (2013)
Future Medicinal Chemistry,volume 5,issue 13 , Vol. 5, Iss. 13, 2013-09 , pp.Anti-neuroinflammatory agents for the treatment of Alzheimer’s disease
By Zhou Wei,Hu Wenhui in (2013)
Future Medicinal Chemistry,volume 5,issue 13 , Vol. 5, Iss. 13, 2013-09 , pp.
Previous
Next